(Q34167869)

31 July 2017

title

Pharmacokinetics and bioavailability of intravenous, intramuscular, and oral lorazepam in humans (English)

1 reference

31 July 2017

1 reference

1 reference

pharmaceutical science

1 reference

https://api.crossref.org/works/10.1002/JPS.2600680119

30 March 2022

1 reference

5

Harmatz JS

1 reference

31 July 2017

1

D. J. Greenblatt

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:31453

30 March 2022

2

R. I. Shader

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:31453

30 March 2022

6

M. D. Allen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:31453

30 March 2022

author name string

K. Franke

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:31453

30 March 2022

D. S. MacLaughlin

4

2 references

31 July 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:31453

30 March 2022

A. Werner

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:31453

30 March 2022

E. Woo

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:31453

30 March 2022

M. D. Allen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:31453

28 October 2022

language of work or name

English

0 references

publication date

1 January 1979

1 reference

full work available at URL

31 July 2017

https://api.elsevier.com/content/article/PII:S0022354915424487?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1002/JPS.2600680119

https://api.elsevier.com/content/article/PII:S0022354915424487?httpAccept=text/plain

30 March 2022

1 reference

https://api.crossref.org/works/10.1002/JPS.2600680119

Journal of Pharmaceutical Sciences

30 March 2022

published in

1 reference

31 July 2017

volume

68

1 reference

31 July 2017

issue

1

1 reference

31 July 2017

page(s)

57-63

1 reference

31 July 2017

cites work

Metabolism of lorazepam

3

48

1017

Elliott

1976

1 reference

https://api.crossref.org/works/10.1002/JPS.2600680119

Biotransformation and excretion of lorazepam in patients with chronic renal failure

30 March 2022

Clinical pharmacokinetics of lorazepam. I. Absorption and disposition of oral 14C-lorazepam

4

volume

3

page(s)

1033

0 references

6

20

329

Greenblatt

1976

1 reference

https://api.crossref.org/works/10.1002/JPS.2600680119

Clinical pharmacokinetics of lorazepam; II. Intramuscular injection

30 March 2022

7

21

222

Greenblatt

1977

1 reference

https://api.crossref.org/works/10.1002/JPS.2600680119

Clinical Pharmacokinetics of Lorazepam. IV. Long-Term Oral Administration

30 March 2022

8

17

495

Greenblatt

1977

1 reference

https://api.crossref.org/works/10.1002/JPS.2600680119

An Algorithm for Least-Squares Estimation of Nonlinear Parameters

30 March 2022

10

11

431

Marquardt

1963

1 reference

https://api.crossref.org/works/10.1002/JPS.2600680119

Assessment of Pharmacokinetic Constants from Postinfusion Blood Curves Obtained after I.V. Infusion

30 March 2022

12

59

53

Loo

1970

1 reference

https://api.crossref.org/works/10.1002/JPS.2600680119

Clinical pharmacokinetics (second of two parts).

30 March 2022

13

293

964

Greenblatt

1975

1 reference

https://api.crossref.org/works/10.1002/JPS.2600680119

Linear pharmacokinetic equations allowing direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of polyexponential equations which have been fitted to the data

30 March 2022

17

4

443

Wagner

1976

1 reference

https://api.crossref.org/works/10.1002/JPS.2600680119

Linear pharmacokinetic models and vanishing exponential terms: implications in pharmacokinetics

30 March 2022

18

4

395

Wagner

1976

1 reference

https://api.crossref.org/works/10.1002/JPS.2600680119

Statistical estimations in pharmacokinetics.

30 March 2022

19

2

123

Boxenbaum

1974

1 reference

https://api.crossref.org/works/10.1002/JPS.2600680119

Bioavailability of drugs: the digoxin dilemma

30 March 2022

20

1

36

Greenblatt

1976

1 reference

https://api.crossref.org/works/10.1002/JPS.2600680119

Relative amnesic actions of diazepam, flunitrazepam and lorazepam in man

30 March 2022

24

4

45

George

1977

1 reference

https://api.crossref.org/works/10.1002/JPS.2600680119

Critical analysis of "flip-flop" phenomenon in two-compartment pharmacokinetic model

30 March 2022

30

65

1140

Byron

1976

1 reference

https://api.crossref.org/works/10.1002/JPS.2600680119

Commentary: a physiological approach to hepatic drug clearance

30 March 2022

31

18

377

Wilkinson

0 references

Diazepam actions and plasma concentrations following ethanol ingestion

32

11

345

MacLeod

1977

1 reference

https://api.crossref.org/works/10.1002/JPS.2600680119

Effect of a cocktail on diazepam absorption

30 March 2022

33

57

199

Greenblatt

1978

1 reference

https://api.crossref.org/works/10.1002/JPS.2600680119

Pharmacokinetic and biopharmaceutic profile of chlordiazepoxide HC1 in healthy subjects: single-dose studies by the intravenous, intramuscular, and oral routes

30 March 2022

34

5

3

Boxenbaum

1977

1 reference

https://api.crossref.org/works/10.1002/JPS.2600680119

Absorption of oral and intramuscular chlordiazepoxide

30 March 2022

35

13

267

Greenblatt

1978

1 reference

https://api.crossref.org/works/10.1002/JPS.2600680119

Pharmacokinetic profile of diazepam in man following single intravenous and oral and chronic oral administrations.

30 March 2022

36

62

1789

Kaplan

1973

1 reference

https://api.crossref.org/works/10.1002/JPS.2600680119

Studies of drugs given before anaesthesia XXVI: lorazepam

30 March 2022

37

49

1047

Dundee

1977

1 reference

https://api.crossref.org/works/10.1002/JPS.2600680119

Lorazepam as a premedication

30 March 2022

38

23

22

Gale

1976

1 reference

https://api.crossref.org/works/10.1002/JPS.2600680119

Respiratory effects and amnesia after premedication with morphine or lorazepam

30 March 2022

42

49

351

Cormack

1977

1 reference

https://api.crossref.org/works/10.1002/JPS.2600680119

Evaluation of anxiolytic and amnesic effects of intramuscular lorazepam as a pre-operative medication

30 March 2022

43

4

388

Paymaster

1976

1 reference

https://api.crossref.org/works/10.1002/JPS.2600680119

Pilot clinical trial of parenteral lorazepam (Temesta�) in anxiety states

30 March 2022

45

33

377

Bobon

1973

1 reference

https://api.crossref.org/works/10.1002/JPS.2600680119

Respiratory effects of lorazepam, pentobarbital, and pentazocine

30 March 2022

46

18

170

Gasser

1975

1 reference

https://api.crossref.org/works/10.1002/JPS.2600680119

Slow absorption of intramuscular chlordiazepoxide

30 March 2022

48

291

1116

Greenblatt

1974

1 reference

https://api.crossref.org/works/10.1002/JPS.2600680119

Plasma diazepam levels after single dose oral and intramuscular administration

30 March 2022

50

30

164

Gamble

0 references

Absorption and sedative effects of diazepam after oral administration and intramuscular administration into the vastus lateralis muscle and the deltoid muscle

51

47

857

Korttila

1975

1 reference

https://api.crossref.org/works/10.1002/JPS.2600680119

The influence of the route of administration on the clinical action of diazepam

30 March 2022

52

30

152

Assaf

1975

1 reference

https://api.crossref.org/works/10.1002/JPS.2600680119

Serum creatine phosphokinase concentrations after intramuscular chlordiazepoxide and its solvent

30 March 2022

56

16

118

Greenblatt

1976

1 reference

https://api.crossref.org/works/10.1002/JPS.2600680119

30 March 2022

Identifiers

1 reference

31 July 2017

1 reference